Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
The Vironova offering comprises:
- Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) for semi-automated nanoparticle analysis.
- Viral clearance testing performed in GLP and BSLIII
- Certified laboratories
- MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.
Job Title: Director, Instruments Business Unit
Job Title: Head of Business Unit, EM Service
Job Title: Strategic development manager
Job Title: Marketing Director
Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency
In this podcast and accompanying article, we interviewed Jonathan Royce, Director, Instruments Business Unit, Vironova about analytics in gene therapy manufacturing. Specifically Jonathan details new technologies to monitor critical quality attributes, reduce development time and increase the number of projects that can be run....Continued
Intelligent Lentivirus Analysis – Coupling an Automated Imaging System with Artificial Intelligence
The number of gene and cell therapies in the clinic is increasing rapidly. With the increase in gene therapy manufacturing, comes the need for improved analytics during the production process. Analytics for Lentivirus production is ... Continued
In-Process Analytical Methods are Critical in Gene Therapy Development
In gene therapy manufacturing, evaluating viral vector stability and integrity is critical in process development prior to production scale up. Process changes can affect critical quality attributes and as a result any process changes need ... Continued
See the quality of your viral particles at different steps of your process
Introduction In Gene Therapy, viral vector stability and integrity must be carefully investigated before scaling up production. Specific process steps can be evaluated to understand what impact they have on viral particle integrity. Viral particle characterization ... Continued
Automated integrity analysis of AAV and Adenovirus particles using MiniTEM
MiniTEM a compact transmission electron microscope innovation by Vironova, simplifies analytical testing of virus particles through automation. This not only saves time but also improves the robustness and reliability of the results by reducing userdependent variability...Continued